WAY-262611
Supplier: Enzo Life Sciences
BML-WN110-0005
BML-WN110-0025
76002-420EA
168.95
USD
76002-420
76002-422
WAY-262611
WAY-262611
DKK1 inhibitor
Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.
Formula:
C₂₀H₂₂N₄ MW: 318.4 g/mol |
MDL Number:
MFCD20527803 CAS Number: 1123231-07-1 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...